11 – 20 of 157
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
The potential radiosensitization target PFKFB3 is related to response to radiotherapy in SweBCG91RT : a randomized clinical trial with long-term follow-up
(
- Contribution to journal › Article
-
Mark
Adverse prognosis gene expression patterns in metastatic castration-resistant prostate cancer
(
- Contribution to journal › Article
-
Mark
Validation of a breast cancer assay for radiotherapy omission : an individual participant data meta-analysis
(
- Contribution to journal › Article
-
Mark
Identifying prognostic targets in metastatic prostate cancer beyond AR
2025) In FEBS Open Bio(
- Contribution to journal › Article
-
Mark
Janus kinase 1 inhibitors for treating immune checkpoint inhibitor-induced enterocolitis - report of two filgotinib-treated cases and literature review
(
- Contribution to journal › Scientific review
-
Mark
Combinatorial DNMTs and EZH2 inhibition reprograms the H3K27me3 and DNAme-mediated onco-epigenome to suppress multiple myeloma proliferation
(
- Contribution to journal › Article
- 2024
-
Mark
The analytical and clinical validity of AI algorithms to score TILs in TNBC : can we use different machine learning models interchangeably?
(
- Contribution to journal › Article
-
Mark
Proteomic profiling reveals that ESR1 mutations enhance cyclin-dependent kinase signaling
(
- Contribution to journal › Article
-
Mark
Clinical cell-surface targets in metastatic and primary solid cancers
(
- Contribution to journal › Article
-
Mark
PVT1 interacts with polycomb repressive complex 2 to suppress genomic regions with pro-apoptotic and tumour suppressor functions in multiple myeloma
(
- Contribution to journal › Article